Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00036491
What this trial is testing

Anti-CD20 in Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Looking for participantsNCT06748001
What this trial is testing

Avapritinib Rollover Study

Who this might be right for
Mastocytosis, Systemic
Blueprint Medicines Corporation 60
Not applicableWithdrawnNCT03204448
What this trial is testing

Clinical Performance of BioCLIA Ro60

Who this might be right for
Systemic Lupus ErythematosusSjogren's Syndrome
HOB Biotech Group
Large-scale testing (Phase 3)Study completedNCT00657540
What this trial is testing

Black Widow Spider Antivenin for Patients With Systemic Latrodectism

Who this might be right for
Latrodectism
Instituto Bioclon S.A. de C.V. 60
Post-approval studies (Phase 4)Study completedNCT04207840
What this trial is testing

Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals

Who this might be right for
PharmacokineticsEpinephrineAlbuterol+2 more
Amphastar Pharmaceuticals, Inc. 28
Large-scale testing (Phase 3)Study completedNCT00987389
What this trial is testing

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

Who this might be right for
Granulomatosis With Polyangiitis (Wegener's) (GPA)Microscopic Polyangiitis (MPA)
University of Pennsylvania 704
Not applicableStudy completedNCT05478018
What this trial is testing

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus ErythematosusInterferon Deficiency
Rigshospitalet, Denmark 55
Early research (Phase 1)WithdrawnNCT00003435
What this trial is testing

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
Duke University
Testing effectiveness (Phase 2)Study completedNCT02885610
What this trial is testing

Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

Who this might be right for
Systemic Lupus Erythematosus
RemeGen Co., Ltd. 249
Not applicableStudy completedNCT07433127
What this trial is testing

Inflammation Indıces and Mortality in Adult Crush Syndrome

Who this might be right for
Crush SyndromeRhabdomyolysisSystemic Inflammatory Response+1 more
Ataturk University 325
Not applicableEnded earlyNCT03186794
What this trial is testing

Aerobic Exercise in Women With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupusAutoimmune Disease+1 more
National Institutes of Health Clinical Center (CC) 24
Not applicableStudy completedNCT02507024
What this trial is testing

The ANCA Vasculitis Questionnaire (AAV-PRO©)

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)Churg-Strauss Syndrome (CSS)Granulomatosis With Polyangiitis (Wegener's) (GPA)+4 more
University of Pennsylvania 280
Large-scale testing (Phase 3)Looking for participantsNCT07176546
What this trial is testing

TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

Who this might be right for
Granulomatosis With PolyangiitisWegener'sGPA
Robert Spiera, MD 30
Not applicableUnknownNCT00294697
What this trial is testing

Genetic Variation and Immune Responses After Injury

Who this might be right for
SepsisPneumoniaTrauma+2 more
National Institute of General Medical Sciences (NIGMS) 2,000
Very early researchLooking for participantsNCT07490041
What this trial is testing

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

Who this might be right for
Rheumatic DiseasesPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)Systemic Lupus Erythematosus (SLE)+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Testing effectiveness (Phase 2)Study completedNCT07281105
What this trial is testing

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Who this might be right for
Neuropsychiatric Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE)Cognitive Impairment
Evergreen Therapeutics, Inc. 131
Not applicableStudy completedNCT07103486
What this trial is testing

Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Novartis Pharmaceuticals 264
Not applicableUnknownNCT05632029
What this trial is testing

Laser Acupuncture in Egyptian Systemic Lupus Females With Insulin Resistance

Who this might be right for
Systemic Lupus ErythematosusPreDiabetes
Cairo University 64
Not applicableLooking for participantsNCT07049653
What this trial is testing

Anifrolumab Pregnancy Study

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 500
Large-scale testing (Phase 3)Study completedNCT01484496
What this trial is testing

Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 839
Next Page